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http://dx.doi.org/10.1016/j.jmii.2012Mucosa-associated lymphoid tissue lymphoma (MALToma) is a type of B-cell lymphoma. Case
reports of childhood thymic MALToma and its association with vasculitis are rarely found in
the related literature. Herein, we present a report of an 11-year and 10-month-old girl who
was initially diagnosed with cutaneous vasculitis characterized by nonthrombocytopenic
palpable purpura, positive antinuclear antibody and anti-SSA (Ro) antibody. Eight months later,
a thymic mediastinal mass was found. Surgical excision was performed and results of patholog-
ical analysis revealed an extranodal marginal zone CD20þ B-cell MALToma. Benign response to
the chemotherapeutic regimen of BerlineFrankfurteMu¨nster group NHL-BFM 90 R2 without
relapse was noted in 2 years of follow-up. For the first time, our case demonstrated some clin-
ical evidence of the association between vasculitis and childhood MALToma.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Mucosa-associated lymphoid tissue lymphoma (MALToma) is
a type of B-cell lymphoma. In adults, it accounts for up to
8% of non-Hodgkin’s lymphoma, and usually occurs in
people who are in their 60s. It can attack stomach, orbit,nt of Pediatrics, National
ng-Shan South Road, Taipei,
et.net (Y.-H. Yang).
an Society of Microbiology. Publ
.06.011intestine, lung, thyroid, salivary gland, skin, soft tissues,
bladder, kidney, and central nervous systems.1,2 To date,
no study has accurately reported on an incidence in
a pediatric group. Patients with MALToma may also have
underlying autoimmune diseases, such as Sjo¨gren’s
syndrome and Hashimoto thyroiditis, or disorders such as
Helicobacter pylori infection.3,4 It is believed that such
a chronic inflammatory process may contribute to the
development of MALToma. Vasculitis is an inflammatory
disorder, however, only one female patient in her forties
with gastric vasculitis and MALToma has been previously
reported by Wo¨hrer et al.3 Conversely, in children, thereished by Elsevier Taiwan LLC. All rights reserved.
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mune diseases in the related literature. We herein present
a rare case of childhood thymic MALToma with cutaneous
vasculitis.Case report
An 11-year and 10-month-old Chinese girl visited our
emergency department complaining of chest pain, fever,
and tachypnea for 6 days. Eight months before admission
she was diagnosed with cutaneous vasculitis, which was
characterized by nonthrombocytopenic purpura over
bilateral lower extremities, positive antinuclear and anti-
Sjogren’s Syndrome A (SSA) antibodies (Fig. 1A) by the
Shands Children’s Hospital, Florida, USA. She had been
receiving immunomodulator (e.g, azathioprine, hydroxy-
chloroquine sulfate) therapy and steroids since then. In
addition, no chest X-ray had been done before this admis-
sion. After admission, we confirmed that her septic shock
was caused by Pseudomonas aeruginosa, and she improved
after receiving appropriate treatment and medication.
The initial chest X-ray showed borderline mediastinal
widening without interstitial lung edema or pleural effusion
(Fig. 1B). A brief cardiac sonography revealed an unknown
mass outside of the right side of the heart. A computerFigure 1. (A) The picture shows nonthrombocytopenic purpura o
mediastinal widening without interstitial lung edema or pleural ef
mass (6.72  5.35 cm2) in the anterior mediastinal area (white arro
extranodal marginal zone B-cell type lymphoma (mucosa-associatetomography (CT) scan demonstrated a huge mass
(6.72  5.35 cm2) over the anterior mediastinal area
(Fig. 1C). A well-capsulated, multilobular mass originating
from the thymus tissue in the anteriorelateral mediastinal
area was found during surgical intervention for mass
removal. Pathological findings indicated a malignant
lymphoma, extranodal marginal zone B-cell type lymphoma
(MALToma) (Fig. 1D).
We checked the immunological profiles of her previous
vasculitis. Our case was found to be positive for antinuclear
antibody (1:320 titer), anti-SSA (Ro) antibody (120 IU/mL),
rheumatoid arthritis (RA) factor (120 IU/mL), and hyper-
gammaglobulinemia [immunoglobulin G (IgG): 30.60 g/L;
IgA: 9.89 g/L; IgM: 1.64 g/L]. No evidence of renal
involvement was found. As compared with her previous skin
appearance, the vasculitis was in the inactive phase. In
addition, the possibility of Sjo¨gren’s syndrome was
excluded by reviewing her related symptoms and based on
the results of the Schirmer’s test.
The tumor-staging work-up demonstrated that the mass
was a localized mediastinal MALToma without metastasis.
Treatment with BerlineFrankfurteMu¨nster group NHL-BFM
90 R2 regimen was completed over the following 6 months.
Despite having high levels of serum SSA (490 AU/mL) and
positive RA factor (169 IU/mL) 2 years after tumor excision
and chemotherapy, her tumor did not relapse during the 2ver the girl’s bilateral legs. (B) Chest X-ray showed borderline
fusion. (C) Computer tomography scans demonstrated a huge
ws). (D) Pathological analysis revealed a malignant lymphoma,
d lymphoid tissue lymphoma).
440 P.-H. Chen et al.years of clinical follow-up. We regularly followed her
malignancy according to her chest radiograph, CT scan, and
the level of serum lactate dehydrogenase. Currently, the
patient receives hydroxychloroquine and is followed up
regularly at pediatric rheumatology and hematology clinics.
Discussion
Our case demonstrated that the thymus could be the orig-
inal site of childhood MALToma. It was remarkable that our
patient who had pre-existing vasculitis was just under the
age of 12. Most patients with MALToma also have accom-
panying autoimmune diseases; these had been older adults
with a median age in the 60s.3 In a review of the related
literature, Wo¨hrer et al reported on 61 patients who had
MALToma and autoimmune disease with an average age
between 48 and 69 years. One of them had pre-existing
vasculitis.3 Maeda et al reported on a 23-year-old woman
with both thymic MALToma and systemic lupus eryth-
ematosus. In the current literature, she was the youngest
case of MALToma.5 To the best of our knowledge, our case
involves the youngest patient and is the only case of
childhood thymic MALToma accompanied by pre-existing
vasculitis.
Although the etiology of the MALToma remains unknown,
it is clear that marginal zone lymphoma often arises in the
setting of chronic inflammation or chronic antigenic stim-
ulation, due to autoimmune disease or infection.3 The most
commonly associated autoimmune disease with MALToma is
Sjo¨gren’s syndrome. However, our patient did not have
Sjo¨gren’s syndrome. High titers of anti-SSA and RA factor
were consistently noted, even after the completion of
lymphoma chemotherapy. One plausible mechanism may be
that the autoantibody or autoimmune process may induce
the development of mediastinal MALToma.
Some studies regarding gene and immunology in MAL-
Toma patients have been reported. One study had revealed
that MALToma may be associated with some genetic
defects, such as mutation of API2-MALT1 gene with
t(11,18).6 Another immunology study showed the rising
expression of inflammation-dependent cytokine receptors,
such as CCR1, CCR8, and CXCR6 in the salivary glands of
MALToma patients.7 Moreover, one of the renowned path-
ogens associated with MALToma was H. pylori.8 Under the
infectious status of H. pylori, MALToma development may
be facilitated by the autoantibody against Helicobacter
sonication, IgG, DNA, and stomach extraction.9
In our case, we did not ascertain as to whether vasculitis
or malignancy occurred first. It is possible that chronic
inflammation, such as vasculitis, induces the development
of MALToma. Most pediatric patients with MALToma have
long-term survival and a good prognosis even with just local
therapy alone.10 As compared with adult-aged patients,
both generally have a favorable prognosis. Furthermore,
both adult and childhood patients had similar symptoms
and signs. For treatment after tumor excision, in the
pediatric group, most of the patients received adjuvant
systemic chemotherapy. In contrast, in the adult group,
they may choose more conservative observation or radia-
tion therapy, except for adjuvant chemotherapy.5,7,11,12Regardless, the possibility of malignancy in pediatric
patients with autoimmune disease should be kept in mind.3
In conclusion, this is the first case report demonstrating
the association between childhood vasculitis and thymic
MALToma. Underlying autoimmune disease or chronic
inflammation may be attributed to the process of onco-
genesis.3 Clinicians might be made aware of the possibility
of malignancy in pediatric patients with autoimmune
disease.Conflicts of interest
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